Milrinone 1 mg/ml Solution for Injection and Infusion.
Adults Short-term therapy (up to 48 hours) of severe cardiac failure, which is not satisfactorily treatable with the usual treatment regimen (cardiac glycosides, diuretics, vasodilators, and angiotensin converting enzyme (ACE) inhibitors). During treatment with milrinone infusion, continuous monitoring of ECG, blood pressure must be ensured. Children In children, milrinone is indicated for short-term therapy (up to 35 hours) of congestive heart failure that is not responsive to standard basic therapy (glycosides, diuretics, vasodilators and / or ACE inhibitors) and for short-term therapy (up to 35 hours) of children with acute cardiac failure, including states of reduced cardiac output (low-output syndrome) status post cardiac surgery.